Impact of bariatric surgery on cardiovascular and renal complications of diabetes: a focus on clinical outcomes and putative mechanisms

References

• Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118(11):1723–1735.. PubMed PMID: PMC4887150
   PubMed Web of Science ®Google Scholar
• Maric-Bilkan C. Obesity and diabetic kidney disease. Med Clin North Am. 2013 Nov 27;97(1):59–74.. PubMed PMID: PMC3539140.
   PubMed Web of Science ®Google Scholar
• Preis SR, Pencina MJ, Mann DM, et al. Early-adulthood cardiovascular disease risk factor profiles among individuals with and without diabetes in the Framingham Heart Study. Diabetes Care. 2013 Jun;36(6):1590–1596. PubMed PMID: 23340887; PubMed Central PMCID: PMCPMC3661800. eng.
   PubMed Web of Science ®Google Scholar
• Saydah S, Bullard KM, Cheng Y, et al. Trends in cardiovascular disease risk factors by obesity level in adults in the United States, NHANES 1999–2010. Obesity (Silver Spring, Md). 2014 Aug;22(8):1888–1895. PubMed PMID: 24733690; PubMed Central PMCID: PMCPMC4560453. eng.
   PubMed Web of Science ®Google Scholar
• Bastien M, Poirier P, Lemieux I, et al. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):369–381. PubMed PMID: 24438728; eng.
   PubMed Web of Science ®Google Scholar
• O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. The Lancet. 2010;376(9735):112–123.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet. 2004;364(9438):937–952.
   PubMed Web of Science ®Google Scholar
• 2017 USRDS annual data report: executive Summary. Am J Kidney Dis. 2018;71(3):S1–S8. Available from: https://doi.org/10.1053/j.ajkd.2018.01.003
   PubMed Web of Science ®Google Scholar
• Weisstuch JM, Dworkin LD. Does essential hypertension cause end-stage renal disease? Kidney Int Supplement. 1992 May;36:S33–7. PubMed PMID: 1614065; eng
   PubMedGoogle Scholar
• Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Reviews Cardiol. 2011 Nov 09;8(1):30–41. PubMed PMID: PMC3033496.
   PubMed Web of Science ®Google Scholar
• Kazancioğlu R. Risk factors for chronic kidney disease: an update. Kidney Int Supplements. 2013 Nov 27;3(4):368–371. PubMed PMID: PMC4089662.
   Web of Science ®Google Scholar
• Djousse L, Kurth T, Gaziano JM. Cystatin C and risk of heart failure in the Physicians’ Health Study (PHS). Am Heart J. 2008 Jan;155(1):82–86.. PubMed PMID: 18082494; PubMed Central PMCID: PMCPMC2179893. eng.
   PubMed Web of Science ®Google Scholar
• Fenske W, Athanasiou T, Harling L, et al. Obesity-related cardiorenal disease: the benefits of bariatric surgery. Nat Reviews Nephrol. 2013 Sep;9(9):539–551. PubMed PMID: 23917797; eng.
   PubMed Web of Science ®Google Scholar
• Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations [10.2337/dc16-0236]. Diabetes Care. 2016;39(6):861.
   PubMed Web of Science ®Google Scholar
• Cummings DE, Arterburn DE, Westbrook EO, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia. 2016 May;59(5):945–953. 10.1007/s00125-016-3903-x. PubMed PMID: 26983924; PubMed Central PMCID: PMCPMC4826815. eng.
   PubMed Web of Science ®Google Scholar
• Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. New England J Med. 2012;366(17):1577–1585. PubMed PMID: 22449317.
   PubMed Web of Science ®Google Scholar
• Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012 Mar 26;366(17):1567–1576. PubMed PMID: PMC3372918.
   PubMed Web of Science ®Google Scholar
• Neff KJ, le Roux CW. Bariatric surgery: traversing the CROSSROADS into mainstream diabetes care. Diabetologia. 2016 Mar 16;59(5):942–944.. PubMed PMID: PMC4826826.
   PubMed Web of Science ®Google Scholar
• Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017 Feb 16;376(7):641–651. PubMed PMID: 28199805; PubMed Central PMCID: PMCPMC5451258. eng.
   PubMed Web of Science ®Google Scholar
• Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet (London, England). 2015 Sep 5;386(9997):964–973. PubMed PMID: 26369473; eng.
   PubMed Web of Science ®Google Scholar
• Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. Jama. 2013 Jun 5;309(21):2240–2249. PubMed PMID: 23736733; PubMed Central PMCID: PMCPMC3954742. eng.
   PubMed Web of Science ®Google Scholar
• Ismail-Beigi F, Craven T, Banerji M, et al. Effect of intensive treatment of hyperglycemia on microvascular complications of type 2 diabetes in ACCORD: a randomized trial. Lancet (London, England). 2010 Jun 30;376(9739):419–430. PubMed PMID: PMC4123233.
   PubMed Web of Science ®Google Scholar
• Nathan DM. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. PubMed PMID: 24356592; PubMed Central PMCID: PMCPMC3867999. eng Diabetes Care. 2014;371:9–16.
   PubMed Web of Science ®Google Scholar
• Nair M, le Roux CW, Docherty NG. Measuring changes in renal function after bariatric surgery: why estimated glomerular filtration rate is not good enough. Surg Obes Relat Dis. 2016;12(10):1897–1898.
   PubMed Web of Science ®Google Scholar
• Li K, Zou J, Ye Z, et al. Effects of bariatric surgery on renal function in obese patients: a systematic review and meta analysis. PloS one. 2016;11(10):e0163907. PubMed PMID: 27701452; PubMed Central PMCID: PMCPMC5049777. eng.
   PubMed Web of Science ®Google Scholar
• Sinha MK, Collazo-Clavell ML, Rule A, et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int. 2007 Jul;72(1):100–107. PubMed PMID: 17377509; eng.
   PubMed Web of Science ®Google Scholar
• Duffey BG, Alanee S, Pedro RN, et al. Hyperoxaluria is a long-term consequence of Roux-en-Y Gastric bypass: a 2-year prospective longitudinal study. J Am Coll Surg. 2010 Jul;211(1):8–15. PubMed PMID: 20610243; eng.
   PubMed Web of Science ®Google Scholar
• Ikramuddin S, Billington CJ, Lee WJ, et al. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. The Lancet Diabetes Endocrino. 2015 Jun;3(6):413–422. PubMed PMID: 25979364; PubMed Central PMCID: PMCPMC4477840. eng.
   PubMed Web of Science ®Google Scholar
• Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013 Mar;273(3):219–234.. PubMed PMID: 23163728; eng.
   PubMed Web of Science ®Google Scholar
• Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. New England J Med. 2007;357(8):741–752. PubMed PMID: 17715408.
   PubMed Web of Science ®Google Scholar
• Eliasson B, Liakopoulos V, Franzen S, et al. Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study. The Lancet Diabetes Endocrino. 2015 Nov;3(11):847–854. PubMed PMID: 26429401; eng.
   PubMed Web of Science ®Google Scholar
• Hallersund P, Sjostrom L, Olbers T, et al. Gastric bypass surgery is followed by lowered blood pressure and increased diuresis - long term results from the Swedish Obese Subjects (SOS) study. PloS one. 2012;7(11):e49696. PubMed PMID: 23209592; PubMed Central PMCID: PMCPMC3510228. eng.
   PubMed Web of Science ®Google Scholar
• Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. Jama. 2012 Jan 4;307(1):56–65. PubMed PMID: 22215166; eng.
   PubMed Web of Science ®Google Scholar
• Carlsson LM, Romeo S, Jacobson P, et al. The incidence of albuminuria after bariatric surgery and usual care in Swedish Obese Subjects (SOS): a prospective controlled intervention trial. Int J Obes (Lond). 2015 Jan;39(1):169–175. PubMed PMID: 24798033; PubMed Central PMCID: PMCPMC4285618. eng.
   PubMed Web of Science ®Google Scholar
• Sjostrom L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. Jama. 2014 Jun 11;311(22):2297–2304. PubMed PMID: 24915261; eng.
   PubMed Web of Science ®Google Scholar
• Belle SH, Berk PD, Chapman WH, et al. Baseline characteristics of participants in the Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) study. Surgery Obesity Related Diseases: off J Am Society Bariatric Surgery. 2013 Nov-Dec;9(6):926–935. PubMed PMID: 23602493; PubMed Central PMCID: PMCPMC3990409. eng.
   PubMed Web of Science ®Google Scholar
• Courcoulas AP, King WC, Belle SH, et al. Seven-year weight trajectories and health outcomes in the longitudinal assessment of bariatric surgery (LABS) study. JAMA Surg. 2017 Dec 6 PubMed PMID: 29214306; eng. Doi: 10.1001/jamasurg.2017.5025.
   PubMed Web of Science ®Google Scholar
• Friedman AN, Wahed AS, Wang J, et al. Effect of bariatric surgery on CKD risk. J Am Soc Nephrology: JASN. 2018 Apr;29(4):1289–1300. PubMed PMID: 29335242; PubMed Central PMCID: PMCPMC5875949. eng.
   PubMed Web of Science ®Google Scholar
• Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013 Jun 4;158(11):825–830.. PubMed PMID: 23732715; eng.
   PubMed Web of Science ®Google Scholar
• Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. New England J Med. 2007;357(8):753–761. PubMed PMID: 17715409.
   PubMed Web of Science ®Google Scholar
• Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004 Dec 23;351(26):2683–2693. PubMed PMID: 15616203; eng.
   PubMed Web of Science ®Google Scholar
• Montero RM, Herath A, Qureshi A, et al. Defining phenotypes in diabetic nephropathy: a novel approach using a cross-sectional analysis of a single centre cohort. Sci Rep. 2018;8(1):53.
   PubMedGoogle Scholar
• Groop PH, Forsblom C, Thomas MC. Mechanisms of disease: pathway-selective insulin resistance and microvascular complications of diabetes. Nat Clin Prac Endocrinol Metabol. 2005 Dec;1(2):100–110.. PubMed PMID: 16929378; eng.
   PubMedGoogle Scholar
• Purnell JQ, Selzer F, Wahed AS, et al. Type 2 diabetes remission rates after laparoscopic gastric bypass and gastric banding: results of the longitudinal assessment of bariatric surgery study. Diabetes Care. 2016 Jul;39(7):1101–1107. PubMed PMID: 27289123; PubMed Central PMCID: PMCPMC4915561. eng.
   PubMed Web of Science ®Google Scholar
• Jc T, le Roux CW, Docherty NG. Cardiovascular, renal and overall health outcomes after bariatric surgery [journal article]. Curr Cardiol Rep. 2015 April 18;17(5):34..
   PubMed Web of Science ®Google Scholar
• Hall JE, Da Silva AA, Do Carmo JM, et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem. 2010 Jun 4;285(23):17271–17276. PubMed PMID: 20348094; PubMed Central PMCID: PMCPMC2878489. eng.
   PubMed Web of Science ®Google Scholar
• Beckman LM, Beckman TR, Earthman CP. Changes in Gastrointestinal Hormones and Leptin after Roux-en-Y Gastric Bypass Procedure: A Review. J Am Diet Assoc. 2010;110(4):571–584.. PubMed PMID: PMC4284064
   PubMedGoogle Scholar
• Nigro E, Scudiero O, Monaco ML, et al. New insight into adiponectin role in obesity and obesity-related diseases. Biomed Res Int. 2014;2014:658913.. PubMed PMID: 25110685; PubMed Central PMCID: PMCPMC4109424. eng
   PubMed Web of Science ®Google Scholar
• Herder C, Peltonen M, Svensson PA, et al. Adiponectin and bariatric surgery: associations with diabetes and cardiovascular disease in the Swedish Obese Subjects Study. Diabetes Care. 2014 May;37(5):1401–1409. PubMed PMID: 24574342; eng.
   PubMed Web of Science ®Google Scholar
• Malin SK, Bena J, Abood B, et al. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery. Diabetes Obes Metab. 2014 Dec;16(12):1230–1238. PubMed PMID: 25132119; PubMed Central PMCID: PMCPMC4227926. eng.
   PubMed Web of Science ®Google Scholar
• Sharma K. The link between obesity and albuminuria: adiponectin and podocyte dysfunction. Kidney Int. 2009 Jul;76(2):145–148.. PubMed PMID: 19404275; eng.
   PubMed Web of Science ®Google Scholar
• Sharma K, Ramachandrarao S, Qiu G, et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest. 2008 May;118(5):1645–1656. PubMed PMID: 18431508; PubMed Central PMCID: PMCPMC2323186. eng.
   PubMed Web of Science ®Google Scholar
• Rutkowski JM, Wang ZV, Park AS, et al. Adiponectin promotes functional recovery after podocyte ablation. J Am Soc Nephrology: JASN. 2013 Feb;24(2):268–282. PubMed PMID: 23334396; PubMed Central PMCID: PMCPMC3559480. eng.
   PubMed Web of Science ®Google Scholar
• Thethi T, Kamiyama M, Kobori H. The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome. Curr Hypertens Rep. 2012;14(2):160–169.. PubMed PMID: PMC3337881
   PubMed Web of Science ®Google Scholar
• Siragy HM, Carey RM. Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. Am J Nephrol. 2010;31(6):541–550. PubMed PMID: 20484892; PubMed Central PMCID: PMCPMC3202956. eng
   PubMed Web of Science ®Google Scholar
• Wickman C, Kramer H. Obesity and kidney disease: potential mechanisms. Semin Nephrol. 2013 Jan;33(1):14–22.. PubMed PMID: 23374890; eng.
   PubMed Web of Science ®Google Scholar
• Endlich N, Kress KR, Reiser J, et al. Podocytes respond to mechanical stress in vitro. J Am Soc Nephrology: JASN. 2001 Mar;12(3):413–422. PubMed PMID: 11181788; eng.
   PubMed Web of Science ®Google Scholar
• Navarro-Diaz M, Serra A, Romero R, et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrology: JASN. 2006 Dec;17(12 Suppl 3):S213–7. PubMed PMID: 17130264; eng.
   PubMedGoogle Scholar
• Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. Jama. 2001 Jul 25;286(4):421–426. PubMed PMID: 11466120; eng.
   PubMed Web of Science ®Google Scholar
• Arnlov J, Evans JC, Meigs JB, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005 Aug 16;112(7):969–975. PubMed PMID: 16087792; eng.
   PubMed Web of Science ®Google Scholar
• Stehouwer CD, Nauta JJ, Zeldenrust GC, et al. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet (London, England). 1992 Aug 8;340(8815):319–323. PubMed PMID: 1353802; eng.
   PubMed Web of Science ®Google Scholar
• Cosson E, Pham I, Valensi P, et al. Impaired coronary endothelium-dependent vasodilation is associated with microalbuminuria in patients with type 2 diabetes and angiographically normal coronary arteries. Diabetes Care. 2006 Jan;29(1):107–112. PubMed PMID: 16373905; eng.
   PubMed Web of Science ®Google Scholar
• Docherty NG, Fandriks L, le Roux CW, et al. Urinary sodium excretion after gastric bypass surgery. Surgery Obesity Related Diseases: off J Am Society Bariatric Surgery. 2017 Sep;13(9):1506–1514. PubMed PMID: 28571926; eng.
   PubMed Web of Science ®Google Scholar
• Hall JE, Do Carmo JM, Da Silva AA, et al. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015 Mar 13;116(6):991–1006. PubMed PMID: 25767285; PubMed Central PMCID: PMCPMC4363087. eng.
   PubMed Web of Science ®Google Scholar
• Sugerman H, Windsor A, Bessos M, et al. Intra-abdominal pressure, sagittal abdominal diameter and obesity comorbidity. J Intern Med. 1997 Jan;241(1):71–79. PubMed PMID: 9042096; eng.
   PubMed Web of Science ®Google Scholar
• Carlyle M, Jones OB, Kuo JJ, et al. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension (Dallas, Tex: 1979). 2002 Feb;39(2 Pt 2):496–501. PubMed PMID: 11882597; eng.
   PubMed Web of Science ®Google Scholar
• Marcus Y, Shefer G, Stern N. Adipose tissue renin-angiotensin-aldosterone system (RAAS) and progression of insulin resistance. Mol Cell Endocrinol. 2013 Sep 25;378(1–2):1–14. PubMed PMID: 22750719; eng.
   PubMed Web of Science ®Google Scholar
• Savoia C, Volpe M, Alonzo A, et al. Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications. Clinical Sci (London, England: 1979). 2009 Nov 9;118(4):231–240. PubMed PMID: 19886866; eng.
   PubMed Web of Science ®Google Scholar
• Standeven KF, Hess K, Carter AM, et al. 2005; Neprilysin, obesity and the metabolic syndrome. Int J Obes. 2011 Nov 02. 358:1031–1040.. PubMed PMID: PMC3040694.
   Google Scholar
• Docherty NG, le Roux CW. Improvements in the metabolic milieu following Roux-en-Y gastric bypass and the arrest of diabetic kidney disease. Exp Physiol. 2014 Sep;99(9):1146–1153.. PubMed PMID: 25085842; eng.
   PubMed Web of Science ®Google Scholar
• le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006 Jan;243(1):108–114. PubMed PMID: 16371744; PubMed Central PMCID: PMCPMC1449984. eng.
   PubMed Web of Science ®Google Scholar
• le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007 Nov;246(5):780–785. PubMed PMID: 17968169; eng.
   PubMed Web of Science ®Google Scholar
• Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007 Oct;87(4):1409–1439.. PubMed PMID: 17928588; eng.
   PubMed Web of Science ®Google Scholar
• Marina AS, Kutina AV, Shakhmatoba EI, et al. Involvement of glucagon-like peptide-1 in the regulation of selective excretion of sodium or chloride ions by the kidneys. Bull Exp Biol Med. 2017 Feb;162(4):436–440. 10.1007/s10517-017-3634-0. PubMed PMID: 28243920; eng.
   PubMed Web of Science ®Google Scholar
• Gutzwiller JP, Tschopp S, Bock A, et al. Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men. J Clin Endocrinol Metab. 2004 Jun;89(6):3055–3061. PubMed PMID: 15181098; eng.
   PubMed Web of Science ®Google Scholar
• Tremaroli V, Karlsson F, Werling M, et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 2015;22(2):228–238.
   PubMed Web of Science ®Google Scholar
• Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010 Dec;59(12):3049–3057. PubMed PMID: 20876719; PubMed Central PMCID: PMCPMC2992765. eng.
   PubMed Web of Science ®Google Scholar
• Tolhurst G, Heffron H, Lam YS, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein–coupled receptor FFAR2 [10.2337/db11-1019]. Diabetes. 2012;61(2):364.
   PubMed Web of Science ®Google Scholar
• Chambers ES, Viardot A, Psichas A, et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2015 Nov;64(11):1744–1754. PubMed PMID: 25500202; PubMed Central PMCID: PMCPMC4680171. eng.
   PubMed Web of Science ®Google Scholar
• Moss JWE, Ramji DP. Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets. Future Med Chem. 2016 June 30;8(11):1317–1330.. PubMed PMID: PMC5382975.
   PubMed Web of Science ®Google Scholar
• Ridker PM. From CRP to IL-6 to IL-1: moving Upstream To Identify Novel Targets for Atheroprotection. Circ Res. 2016;118(1):145–156.. PubMed PMID: PMC4793711
   PubMed Web of Science ®Google Scholar
• García-García PM, Getino-Melián MA, Domínguez-Pimentel V, et al. Inflammation in diabetic kidney disease. World J Diabetes. 2014;5(4):431–443. PubMed PMID: PMC4127580. 08/1510/04/received02/24/revised06/10/accepted..
   PubMedGoogle Scholar
• Charo IF, Taub R. Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nat Rev Drug Discov. 2011;10(5):365–376.. PubMed PMID: PMC3947588
   PubMed Web of Science ®Google Scholar
• Ridker PM, Luscher TF. Anti-inflammatory therapies for cardiovascular disease. Eur Heart J. 2014 Jul 14;35(27):1782–1791.. PubMed PMID: 24864079; PubMed Central PMCID: PMCPMC4155455. eng.
   PubMed Web of Science ®Google Scholar
• Perez-Gomez MV, Sanchez-Nino MD, Sanz AB, et al. Targeting inflammation in diabetic kidney disease: early clinical trials. Expert Opin Investig Drugs. 2016 Sep;25(9):1045–1058. PubMed PMID: 27268955; eng.
   PubMed Web of Science ®Google Scholar
• Rao SR. Inflammatory markers and bariatric surgery: a meta-analysis. Inflammation Res: off J European Histamine Res Society [Et Al]. 2012 Aug;61(8):789–807.. PubMed PMID: 22588278; eng.
   PubMed Web of Science ®Google Scholar
• Fenske WK, Dubb S, Bueter M, et al. Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study. Surg Obes Relat Dis. 2013;9(4):559–568.
   PubMed Web of Science ®Google Scholar
• Mauricio MD, Aldasoro M, Ortega J, et al. Endothelial dysfunction in morbid obesity. Curr Pharm Des. 2013;19(32):5718–5729. PubMed PMID: 23448493; eng.
   PubMed Web of Science ®Google Scholar
• Iantorno M, Campia U, Di Daniele N, et al. Obesity, inflammation and endothelial dysfunction. J Biol Regul Homeost Agents. 2014 Apr-Jun;28(2):169–176. PubMed PMID: 25001649; eng.
   PubMed Web of Science ®Google Scholar
• Bays HE, Toth PP, Kris-Etherton PM, et al. Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. J Clin Lipidol. 2013 Jul-Aug;7(4):304–383. PubMed PMID: 23890517; eng.
   PubMed Web of Science ®Google Scholar
• Lüscher TF, Landmesser U, von Eckardstein A, et al. High-Density Lipoprotein [10.1161/CIRCRESAHA.114.300935]. Circ Res. 2014;114(1):171.
   PubMedGoogle Scholar
• Osto E, Doytcheva P, Corteville C, et al. Rapid and body weight-independent improvement of endothelial and high-density lipoprotein function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1. Circulation. 2015 Mar 10;131(10):871–881. PubMed PMID: 25673670; eng.
   PubMed Web of Science ®Google Scholar
• Abel ED, Litwin SE, Sweeney G. Cardiac remodeling in obesity. Physiol Rev. 2008 Apr;88(2):389–419.. PubMed PMID: 18391168; PubMed Central PMCID: PMCPMC2915933. eng.
   PubMed Web of Science ®Google Scholar
• Aggarwal R, Harling L, Efthimiou E, et al. The effects of bariatric surgery on cardiac structure and function: a systematic review of cardiac imaging outcomes. Obes Surg. 2016 May;26(5):1030–1040. 10.1007/s11695-015-1866-5. PubMed PMID: 26328532; eng.
   PubMed Web of Science ®Google Scholar
• Garza CA, Pellikka PA, Somers VK, et al. Structural and functional changes in left and right ventricles after major weight loss following bariatric surgery for morbid obesity. Am J Cardiol. 2010 Feb 15;105(4):550–556. PubMed PMID: 20152253; eng.
   PubMed Web of Science ®Google Scholar
• Benotti PN, Wood GC, Carey DJ, et al. Gastric bypass surgery produces a durable reduction in cardiovascular disease risk factors and reduces the long‐term risks of congestive heart failure. J Am Heart Association: Cardiovasc Cerebrovasc Dis. 2017;6(5). pii:e005126. doi: 10.1161/JAHA.116.005126.
   Google Scholar
• Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. Jama. 2008 Jan 23;299(3):316–323. PubMed PMID: 18212316; eng.
   PubMed Web of Science ®Google Scholar
• Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ: Br Med J. 2000 Mar 20; 321(7258):405–412. accepted. PubMed PMID: PMC27454.
   PubMed Web of Science ®Google Scholar
• Dixon JB, le Roux CW, Rubino F, et al. Bariatric surgery for type 2 diabetes. The Lancet. 2012;379(9833):2300–2311.
   PubMed Web of Science ®Google Scholar
• NIH US National Library of Medicine. Prevention and treatment of diabetes complications with gastric surgery or intensive medicines (PRODIGIES). 2013, Nov 1. [cited 2018 Sep 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT01974544
   Google Scholar
• Cohen RV, Pereira TV, Aboud CM, et al. Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial [10.1136/bmjopen-2016-013574]. BMJ Open. 2017;7:1.
   Google Scholar
• Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes — 3-year outcomes. New England J Med. 2014;370(21):2002–2013. PubMed PMID: 24679060.
   PubMed Web of Science ®Google Scholar